Jeffrey R. Baxter
2019
In 2019, Jeffrey R. Baxter earned a total compensation of $1.4M as President and Chief Executive Officer at VBI Vaccines, a 8% decrease compared to previous year.
Compensation breakdown
| Bonus | $175,000 |
|---|---|
| Option Awards | $643,500 |
| Salary | $500,000 |
| Other | $61,128 |
| Total | $1,379,628 |
Baxter received $643.5K in option awards, accounting for 47% of the total pay in 2019.
Baxter also received $175K in bonus, $500K in salary and $61.1K in other compensation.
Rankings
In 2019, Jeffrey R. Baxter's compensation ranked 7,753rd out of 13,971 executives tracked by ExecPay. In other words, Baxter earned more than 44.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,753 out of 13,971 | 45th |
Division Manufacturing | 3,033 out of 5,695 | 47th |
Major group Chemicals And Allied Products | 1,140 out of 2,194 | 48th |
Industry group Drugs | 973 out of 1,880 | 48th |
Industry Pharmaceutical Preparations | 722 out of 1,392 | 48th |
Source: SEC filing on April 28, 2020.
Baxter's colleagues
We found two more compensation records of executives who worked with Jeffrey R. Baxter at VBI Vaccines in 2019.
News
VBI Vaccines CEO Jeffrey Baxter's 2023 pay falls 51% to $894K
April 29, 2024
VBI Vaccines CEO Jeffrey Baxter's 2022 pay falls 47% to $1.8M
May 1, 2023
VBI Vaccines CEO Jeffrey Baxter's 2021 pay jumps 54% to $3.5M
April 29, 2022
VBI Vaccines CEO Jeffrey Baxter's 2020 pay jumps 63% to $2.2M
April 26, 2021
VBI Vaccines CEO Jeffrey Baxter's 2019 pay slips 8% to $1.4M
April 28, 2020
VBI Vaccines CEO Jeffrey Baxter's 2018 pay jumps 81% to $1.5M
April 29, 2019